86 related articles for article (PubMed ID: 16531008)
1. Effect of glutamate ingestion on whole-body glutamate turnover in healthy elderly and patients with chronic obstructive pulmonary disease.
Rutten EP; Engelen MP; Wouters EF; Deutz NE; Schols AM
Nutrition; 2006 May; 22(5):496-503. PubMed ID: 16531008
[TBL] [Abstract][Full Text] [Related]
2. Metabolic effects of glutamine and glutamate ingestion in healthy subjects and in persons with chronic obstructive pulmonary disease.
Rutten EP; Engelen MP; Wouters EF; Schols AM; Deutz NE
Am J Clin Nutr; 2006 Jan; 83(1):115-23. PubMed ID: 16400059
[TBL] [Abstract][Full Text] [Related]
3. Metabolic and functional effects of glutamate intake in patients with chronic obstructive pulmonary disease (COPD).
Rutten EP; Engelen MP; Gosker H; Bast A; Cosemans K; Vissers YL; Wouters EF; Deutz NE; Schols AM
Clin Nutr; 2008 Jun; 27(3):408-15. PubMed ID: 18433945
[TBL] [Abstract][Full Text] [Related]
4. Decreased whole-body and splanchnic glutamate metabolism in healthy elderly men and patients with chronic obstructive pulmonary disease in the postabsorptive state and in response to feeding.
Rutten EP; Engelen MP; Castro CL; Wouters EF; Schols AM; Deutz NE
J Nutr; 2005 Sep; 135(9):2166-70. PubMed ID: 16140893
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease.
Kirkil G; Hamdi Muz M; Seçkin D; Sahin K; Küçük O
Respir Med; 2008 Jun; 102(6):840-4. PubMed ID: 18295467
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the beta2 adrenoreceptor gene in chronic obstructive pulmonary disease.
Vacca G; Schwabe K; Dück R; Hlawa HP; Westphal A; Pabst S; Grohé C; Gillissen A
Ther Adv Respir Dis; 2009 Feb; 3(1):3-10. PubMed ID: 19293197
[TBL] [Abstract][Full Text] [Related]
7. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
8. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
9. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
[TBL] [Abstract][Full Text] [Related]
10. Measurement of the total antioxidant potential in chronic obstructive pulmonary diseases with a novel automated method.
Ceylan E; Gencer M; Uzer E; Celik H
Saudi Med J; 2007 Sep; 28(9):1339-43. PubMed ID: 17768456
[TBL] [Abstract][Full Text] [Related]
11. The pattern of amino acid exchange across the brain is unaffected by intravenous glutamine supplementation in head trauma patients.
Berg A; Bellander BM; Wanecek M; Norberg A; Ungerstedt U; Rooyackers O; Wernerman J
Clin Nutr; 2008 Dec; 27(6):816-21. PubMed ID: 18649974
[TBL] [Abstract][Full Text] [Related]
12. Cognitive function and its effects on the quality of life status in the patients with chronic obstructive pulmonary disease (COPD).
Salik Y; Ozalevli S; Cimrin AH
Arch Gerontol Geriatr; 2007; 45(3):273-80. PubMed ID: 17343931
[TBL] [Abstract][Full Text] [Related]
13. Plasma branched-chain amino acid levels and muscle energy metabolism in patients with chronic obstructive pulmonary disease.
Kutsuzawa T; Shioya S; Kurita D; Haida M
Clin Nutr; 2009 Apr; 28(2):203-8. PubMed ID: 19250720
[TBL] [Abstract][Full Text] [Related]
14. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of an ultralong sustained-release theophylline formulation when given twice daily in elderly patients with chronic obstructive pulmonary disease: monitoring implications.
Armijo JA; Sánchez BM; Peralta FG; González-Ruiz M; Cuadrado A; Verdejo A; Cos MA; Arjona R
Biopharm Drug Dispos; 2003 May; 24(4):165-71. PubMed ID: 12698500
[TBL] [Abstract][Full Text] [Related]
16. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD.
Ramachandran K; McCusker C; Connors M; Zuwallack R; Lahiri B
Chron Respir Dis; 2008; 5(4):205-9. PubMed ID: 19029231
[TBL] [Abstract][Full Text] [Related]
17. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
Majumdar S; Sen S; Mandal SK
J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
[TBL] [Abstract][Full Text] [Related]
18. Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression.
Brajer B; Batura-Gabryel H; Nowicka A; Kuznar-Kaminska B; Szczepanik A
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():145-52. PubMed ID: 19218638
[TBL] [Abstract][Full Text] [Related]
19. Diuretics, plasma brain natriuretic peptide and chronic obstructive pulmonary disease.
Kanat F; Vatansev H; Teke T
Neth J Med; 2007 Sep; 65(8):296-300. PubMed ID: 17890789
[TBL] [Abstract][Full Text] [Related]
20. Anatomical distribution of 3He apparent diffusion coefficients in severe chronic obstructive pulmonary disease.
Evans A; McCormack D; Ouriadov A; Etemad-Rezai R; Santyr G; Parraga G
J Magn Reson Imaging; 2007 Dec; 26(6):1537-47. PubMed ID: 17968961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
